rawfin.tv
Quoin Pharmaceuticals Establishes Japan Subsidiary for QRX003 Commercialization
MarketsstocksAI Generated

Quoin Pharmaceuticals Establishes Japan Subsidiary for QRX003 Commercialization

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Quoin Pharmaceuticals has completed the establishment of a wholly-owned subsidiary in Japan. This strategic move aims to advance the commercial readiness of its product QRX003 in the Japanese market.

PharmaceuticalsJapan MarketCommercializationBiotech

Related Articles

S&P 500 Heavyweights Face Earnings Test Amid Fed Meeting

S&P 500 Heavyweights Face Earnings Test Amid Fed Meeting

stocks
China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks